Unifirst Corp: Form 10-Q for the period ended Feb 24, 2024
Filed with the SEC on Apr 4, 2024 and accepted by EDGAR at Apr 4, 2024, 14:07 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2024-02-24. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2023-11-26 to 2024-02-24 | $590.7m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 6 months2023-08-27 to 2024-02-24 | $1.18bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2023-11-26 to 2024-02-24 | $396.2m | us-gaap:CostOfRevenue |
| Cost of revenue | 6 months2023-08-27 to 2024-02-24 | $780.0m | us-gaap:CostOfRevenue |
| Selling, general and administrative | 3 months2023-11-26 to 2024-02-24 | $131.4m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months2023-08-27 to 2024-02-24 | $254.3m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2023-11-26 to 2024-02-24 | $27.9m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2023-08-27 to 2024-02-24 | $81.1m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2023-11-26 to 2024-02-24 | $7.3m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2023-08-27 to 2024-02-24 | $20.2m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2023-11-26 to 2024-02-24 | $20.5m | us-gaap:NetIncomeLoss |
| Net income | 6 months2023-08-27 to 2024-02-24 | $62.8m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2023-11-26 to 2024-02-24 | $1.09 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2023-08-27 to 2024-02-24 | $3.35 | us-gaap:EarningsPerShareDiluted |
| Diluted shares (weighted) | 3 months2023-11-26 to 2024-02-24 | 18,754,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2023-08-27 to 2024-02-24 | 18,758,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2023-08-27 to 2024-02-24 | $106.7m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2023-08-27 to 2024-02-24 | $72.9m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 6 months2023-08-27 to 2024-02-24 | $11.5m | us-gaap:PaymentsOfDividends |
| Share repurchases | 6 months2023-08-27 to 2024-02-24 | $8.1m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2024-02-24 | $90.5m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2024-02-24 | $864.5m | us-gaap:AssetsCurrent |
| Total assets | At period end2024-02-24 | $2.62bn | us-gaap:Assets |
| Current liabilities | At period end2024-02-24 | $262.9m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2024-02-24 | $571.3m | us-gaap:Liabilities |
| Shareholders' equity | At period end2024-02-24 | $2.05bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000950170-24-041726. Last ingested by Listed: Oct 27, 2026, 16:51 ET. Listed shows no prices and gives no investment advice.